Table 3.
Influence of phenolic compounds in gut microbiota composition.
Polyphenol Type | Tested Bacteria | Growth (+)/Inhibitory (−) Effect | Type of Study | Methods Used | Duration | Doses | References |
---|---|---|---|---|---|---|---|
IN VITRO CELL CULTURE STUDIES | |||||||
Flavonols | |||||||
Quercetin | |||||||
Bacteroides galacturonicus | (−) | In vitro | Counting on culture medium | 24 h | 4, 20 or 50 μg/mL | [166] | |
Lactobacillus sp. | (−) | ||||||
Enterococcus caccae | (−) | ||||||
Bifidobacterium catenulatum | (−) | ||||||
Ruminococcus gauvreauii | (−) | ||||||
Escherichia coli | (−) | ||||||
Rutin | 20, 100 or 250 μg/mL | ||||||
Bacteroides galacturonicus, | NS | ||||||
Lactobacillus sp. | (+) | ||||||
Enterococcus caccae | NS | ||||||
Bifidobacterium catenulatum | (−) | ||||||
Ruminococcus gauvreauii | NS | ||||||
Escherichia coli | (−) | ||||||
Flavonols | Bifidobacterium adolescentis | In vitro | Counting on culture medium | 24 h | flavonol (galangin,kaempferol, quercetin, myricetin, or fisetin dissolved in dimethylsulphoxide (DMSO); final 25 µM; final 0.1% DMSO | [168] | |
Galangin | (−) | ||||||
Kaempferol | NS | ||||||
Quercetin | NS | ||||||
Myricetin | NS | ||||||
Fisetin | NS | ||||||
Isoflavones | MIC (μg/mL) | In vitro | Minimum Inhibitory Concentration Assay (MIC) | 1 h | Concentrations ranging from 62.5 to 1000 μg/mL | [170] | |
Daidzein | Eschericia coli | 1000 | |||||
Staphylococcus aureus | 125 | ||||||
Salmonella typhimirum | 1000 | ||||||
Lactobacillus rhamnosus | 1000 | ||||||
Genistein | Eschericia coli | 1000 | |||||
Staphylococcus aureus | 125 | ||||||
Salmonella typhimirum | 1000 | ||||||
Lactobacillus rhamnosus | 1000 | ||||||
Flavanones | MIC (μg/mL) | In vitro | Minimum Inhibitory Concentration Assay (MIC) | 1 h | Concentrations ranging from 62.5 to 1000 μg/mL | [169] | |
Naringenin | Eschericia coli | 125 | |||||
Staphylococcus aureus | 62.5 | ||||||
Salmonella typhimirum | 125 | ||||||
Lactobacillus rhamnosus | 125 | ||||||
Phenolic acids | MIC (μg/mL) | In vitro | Minimum Inhibitory Concentration Assay (MIC) | 1 h | Concentrations ranging from 62.5 to 1000 μg/mL | [169] | |
caffeic acid | Eschericia coli | 500 | |||||
Staphylococcus aureus | 125 | ||||||
Salmonella typhimirum | 500 | ||||||
Lactobacillus rhamnosus | ≤250 | ||||||
chlorogenic acid | Eschericia coli | 1000 | |||||
Staphylococcus aureus | 125 | ||||||
Salmonella typhimirum | 1000 | ||||||
Lactobacillus rhamnosus | ≤250 | ||||||
o-coumaric acid | Eschericia coli | 250 | |||||
Staphylococcus aureus | 125 | ||||||
Salmonella typhimirum | 250 | ||||||
Lactobacillus rhamnosus | 250 | ||||||
p-coumaric acid | Eschericia coli | 500 | |||||
Staphylococcus aureus | 125 | ||||||
Salmonella typhimirum | 500 | ||||||
Lactobacillus rhamnosus | 500 | ||||||
Ellagitannins | POMx | In vitro | Liquid culturing method | POMx (100 mL) | comercial extract of pomegranate at 0.01% as well as the effect of its main constituents (0.05%) | [175] | |
Extract of pomegranate (POMx) and its main constituents (punicalagins, punicalins, elagic acid, gallic acid) | L. acidophilus | (+) | |||||
L. casei ssp. casei | NS | ||||||
L. paracasei ssp. | NS | ||||||
L. pentosus | (+) | ||||||
L. rhamnosus | (+) | ||||||
B. breve | (+) | ||||||
B. infantis | (+) | ||||||
B. longum | NS | ||||||
B. bifidum | (+) | ||||||
B. animalis ssp. lactis | NS | ||||||
Bacteroides fragilis | NS | ||||||
C. perfringens | (−) | ||||||
Clostridium clostriidoforme | NS | ||||||
C. ramosum | (−) | ||||||
S. aureus | (−) | ||||||
Punicalagin | |||||||
L. acidophilus | NS | ||||||
L. casei ssp. casei | NS | ||||||
L. paracasei ssp. | NS | ||||||
L. pentosus | NS | ||||||
L. rhamnosus | NS | ||||||
B. breve | (+) | ||||||
B. infantis | NS | ||||||
B. longum | NS | ||||||
B. bifidum | NS | ||||||
B. animalis ssp. lactis | (+) | ||||||
Bacteroides fragilis | NS | ||||||
C. perfringens | (−) | ||||||
Clostridium clostriidoforme | (−) | ||||||
C. ramosum | (−) | ||||||
S. aureus | (−) | ||||||
Punicalin | |||||||
L. acidophilus | NS | ||||||
L. casei ssp. casei | NS | ||||||
L. paracasei ssp. | NS | ||||||
L. pentosus | NS | ||||||
L. rhamnosus | NS | ||||||
B. breve | NS | ||||||
B. infantis | NS | ||||||
B. longum | NS | ||||||
B. bifidum | NS | ||||||
B. animalis ssp. lactis | (+) | ||||||
Bacteroides fragilis | NS | ||||||
C. perfringens | NS | ||||||
Clostridium clostriidoforme | NS | ||||||
C. ramosum | NS | ||||||
S. aureus | NS | ||||||
IN VITRO FAECAL MICROBIOTA STUDIES | |||||||
Flavonols | Erysipelotrichaceae | (−) | In vitro | 16S rDNA reads | 6 weeks | 30 mg/kg BW/day | [167] |
Quercetin | Ruminococcaceae | NS | |||||
Clostridiaceae | NS | ||||||
Bacteroidaceae | NS | ||||||
Lachnospiraceae | NS | ||||||
Acidaminococcaceae | NS | ||||||
Eubacteriaceae | NS | ||||||
Prevotellaceae | NS | ||||||
Acholeplasmataceae | NS | ||||||
Lactobacillaceae | NS | ||||||
Graciibacteraceae | NS | ||||||
Clostridium aldenense | NS | ||||||
Clostridium hathewayi | NS | ||||||
Bacteroides vulgatus | (+) | ||||||
Clostridium clariflavum | (+) | ||||||
Clostridium methylpentosum | NS | ||||||
Clostridium sp. C9 | NS | ||||||
Clostridium sp. XB90 | NS | ||||||
Clostridium sp. MLG661 | (+) | ||||||
Blautia stercoris | NS | ||||||
Gracilibacter thermotolerans | NS | ||||||
Parabacteroides distansonis | NS | ||||||
Eubacterium cylindroides | (−) | ||||||
Akkermansia muciniphila | NS | ||||||
Bilophila wadsworthia | NS | ||||||
Bacteroides sp. dnLKV7 | NS | ||||||
Barnesiella intestinihominis | NS | ||||||
Bacteroides sp. S-18 | NS | ||||||
Bacteroides chinchillae | NS | ||||||
Candidatus Prevotella conceptionensis | NS | ||||||
Flavanols | 10 h (150 mg/L) | 150 mg/L and 1000 mg/L | [171] | ||||
(+)-catechin | Bifidobacterium spp. | (+) | 17 h (1000 mg/L) | 150 mg/L and 1000 mg/L | |||
Bacteroides spp. | NS | ||||||
Lactobacillus/Enterococcus spp. | NS | ||||||
Clostridium coccoides–Eubacterium rectale group | (+) | ||||||
C. histolyticum group | (−) | In vitro | Fluorescent in situ hybridization (FISH) | ||||
Escherichia coli | (+) | ||||||
(−)-epicatechin | |||||||
Bifidobacterium spp. | NS | ||||||
Bacteroides spp. | NS | ||||||
Lactobacillus/Enterococcus spp. | NS | ||||||
Clostridium coccoides–Eubacterium rectale group | (+) | ||||||
C. histolyticum group | NS | ||||||
Escherichia coli | NS | ||||||
Flavan-3-ols | Lactobacillus/Enterococcus | (+) | In vitro | Fluorescent in situ hybridization (FISH) | Samples were collected at 0, 5, 10, 24, 30 and 48 h of fermentation | 600 mg/L | [172] |
2 fractions of grape seed | Clostridium histolyticum | (−) | Human fecal microbiota | ||||
Anthocyanins | In vitro | Fluorescent in situ hybridization (FISH) | 0, 1, 2, 4, 5, 10, and 24 h | 20 mg/L and 200 mg/L | [174] | ||
Malvidin-3-glucoside | Total bacteria count | (+) | |||||
Atopobium spp. | (+) | ||||||
Bif idobacterium spp. | (+) | ||||||
C. cocoides−Eubacterium rectale | (+) | ||||||
Bacteroides spp. | (−) | ||||||
Lactobacillus spp. | (+) | ||||||
Clostridium histolyticum | (−) | ||||||
Stilbenes | Erysipelotrichaceae | NS | In vitro | 16S rDNA reads | 6 weeks | 15 mg/kg BW/day | [167] |
Trans-resveratrol | Ruminococcaceae | NS | |||||
Clostridiaceae | NS | ||||||
Bacteroidaceae | NS | ||||||
Lachnospiraceae | NS | ||||||
Acidaminococcaceae | NS | ||||||
Eubacteriaceae | NS | ||||||
Prevotellaceae | NS | ||||||
Acholeplasmataceae | NS | ||||||
Lactobacillaceae | NS | ||||||
Graciibacteraceae | (−) | ||||||
Clostridium aldenense | (−) | ||||||
Clostridium hathewayi | (−) | ||||||
Bacteroides vulgatus | NS | ||||||
Clostridium clariflavum | NS | ||||||
Clostridium methylpentosum | NS | ||||||
Clostridium sp. C9 | (−) | ||||||
Clostridium sp. XB90 | (+) | ||||||
Clostridium sp. MLG661 | (−) | ||||||
Blautia stercoris | NS | ||||||
Gracilibacter thermotolerans | (−) | ||||||
Parabacteroides distansonis | (−) | ||||||
Eubacterium cylindroides | NS | ||||||
Akkermansia muciniphila | NS | ||||||
Bilophila wadsworthia | NS | ||||||
Bacteroides sp. dnLKV7 | NS | ||||||
Barnesiella intestinihominis | NS | ||||||
Bacteroides sp. S-18 | NS | ||||||
Bacteroides chinchillae | NS | ||||||
Candidatus Prevotella conceptionensis | NS | ||||||
Phenolic acids | Total bacteria count | (+) | In vitro | Fluorescent in situ hybridization (FISH) | 0, 1, 2, 4, 5, 10, and 24 h | 150 mg/L and 1000 mg/L | [174] |
Gallic acid | Atopobium spp. | (+) | |||||
Bif idobacterium spp. | (+) | ||||||
C. cocoides−Eubacterium rectale | (+) | ||||||
Bacteroides spp. | (−) | ||||||
Lactobacillus spp. | (+) | ||||||
Clostridium histolyticum | (−) | ||||||
Ellagitannins | Total bacteria | (+) | In vitro | batch-culture fermentation system inoculated with fecal samples from healthy individuals, FISH | Samples collected at 0, 5, 10, 24 and 48 h | POMx (1.5 mL) and punicalagins (250 mg) were inoculated in stirring batch-culture vessels (one per treatment) containing faecal slurry (1:10, w/v). | [175] |
pomegranate by-product (POMx) | Bifidobacterium spp. | (+) | |||||
Lactobacillus spp. | (+) | ||||||
Clostridium coccoides–Eubacterium rectale group C. histolyticum group | (+) | ||||||
NS | |||||||
Lignans | Lactobacillus rhamnosus VTT E-97800 | (+) | In vitro colon model | Counting on culture medium | 0, 2, 4, 6, 8, and 24 h | 8 mL of fecal suspension, and a 16.7% (w/v) final concentration of fresh fecal matter | [179] |
Lignins | L. rhamnosus VTT E-97948 | (+) | |||||
Lactobacillus paracasei VTT E-97949 | (+) | ||||||
Lactobacillus salivarius VTT E-981006 | (+) | ||||||
Bifidobacterium adolescentis VTT E-981074, Bifidobacterium breve VTT E-981075, Bifidobacterium longum VTT E-96664 | (+) | ||||||
Lactobacillus rhamnosus VTT E-97800, | (+) | ||||||
L. rhamnosus VTT E-97948 | (+) | ||||||
IN VIVO STUDIES | |||||||
Isoflavones | Clostridium coccoides-Eubacterium rectale cluster | (+) | In vivo | FISH and flow cytometry analyses | 2 months (Fecal samples were collected on day 0, 30, and 60) | 100 mg/day of isoflavones aglycon equivalents | [170] |
Lactobacillus-Enterococcus group, | (+) | ||||||
Faecalibacterium prausnitzii subgroup, Bifidobacterium genus | (+) | ||||||
Clostridium coccoides-Eubacterium rectale cluster | (+) | ||||||
Condensed Tannins | Lachnospiraceae | (+) | In vivo | culture-independent barcoded next generation sequencing | 3 days normal diet | 1% w/w Grape Seed Extract | [173] |
Proanthocyanidins | Clostridiales | (+) | 6 days treatment diet | ||||
Lactobacillus | (+) | 3 days post treatment control-feeding | |||||
Ruminococcaceae | (+) | fecessamples taken daily | |||||
Stilbenes | In vivo | Agar dilution method | 25 days | 1 mg/kg/day | [179] | ||
Resveratrol | Lactobacillus | (+) | |||||
Bifidobacterium | (+) | ||||||
Enterobacteria | Diminished the increase | ||||||
Stilbenes | Bacteroidetes-to-Firmicutes ratio, | (+) | In vivo | FISH and flow cytometry | 12 weeks | 200 mg/kg/day | [180] |
Resveratrol | Enterococcus faecalis | (−) | |||||
Lactobacillus | (+) | ||||||
Bifidobacterium | (+) | ||||||
Ellagitannins | Lactobacilli | (+) | In vivo | Agar dilution method with fecal microbiota of rats | Samples collected at days 0, 10, 20 | 250 mg/kg/day | [177] |
Pomegranate ellagitannins and their microbiota-derived metabolite urolithin A | Bifidobacterium | (+) | |||||
Ellagitannins | Actinobacteria | (+) | In vivo | FISH and flow cytometry | 4 weeks | 1000 mg POM extract | [178] |
Pomegranate (POM) ellagitannins | Firmicutes | (−) | |||||
Verrucomicrobia (Akkermansia muciniphila) | (+) | ||||||
Butyrivibrio | (+) | ||||||
Enterobacter | (+) | ||||||
Eschericia | (+) | ||||||
Lactobacillus | (+) | ||||||
Prevotella | (+) | ||||||
Serratia | (+) | ||||||
Veillonella | (+) | ||||||
Collinsella | (−) |
NS: no significant difference, (+): increase, (−): decrease.